Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Bloomberg
Wednesday, February 29, 2012 - 10:12am
tags:
obesity, M&A, Vivus, Qnexa, JNJ, Merck, Bristol-Myers Squibb, Arena Pharmaceuticals, Orexigen
Study Suggests a Link Between Sleeping Pills, Early Death
WSJ Online
Wednesday, February 29, 2012 - 10:10am
tags:
insomnia, sleep aid, early death
Don't Count Vertex Out Just Yet
Motley Fool
Wednesday, February 29, 2012 - 10:09am
tags:
Vertex, Incivek, hepatitis C, Merck, Roche
Pfizer recalls expired lot of Prevnar vaccine
Reuters
Wednesday, February 29, 2012 - 10:07am
tags:
Pfizer, recalls, vaccines, Prevnar
Ariad shares fall after posting wider 4th-qtr loss
Yahoo/AP
Wednesday, February 29, 2012 - 10:07am
tags:
earnings, Ariad Pharmaceuticals
4-Star Stocks Poised to Pop: Bristol-Myers
Motley Fool
Wednesday, February 29, 2012 - 10:06am
tags:
Bristol-Myers Squibb
IPO Preview: Argos Therapeutics
Seeking Alpha
Wednesday, February 29, 2012 - 10:05am
tags:
IPOs, Argos, GSK, Novartis, Pfizer, ONYX Pharmaceuticals
Ampio: On The Trail Of An Osteoarthritis Winner
Seeking Alpha
Wednesday, February 29, 2012 - 10:04am
tags:
Ampio, osteoarthritis, Ampion
Merck Warned by FDA on Failure to Study Januvia Treatment for Side Effects
Bloomberg
Tuesday, February 28, 2012 - 1:46pm
tags:
FDA, Januvia, Merck, Janumet, diabetes
Heinz Eyes Pfizer's Baby Food
Yahoo/Zacks
Tuesday, February 28, 2012 - 1:45pm
tags:
Pfizer, infant nutrition, Heinz
FDA adds diabetes, memory loss warnings to statins
Reuters
Tuesday, February 28, 2012 - 1:44pm
tags:
statins, diabetes, FDA
Endo says Opana ER supply disruption will be temporary
InPharm
Tuesday, February 28, 2012 - 11:01am
tags:
Endo, Opana ER, drug shortage
BioDelivery Sciences, FDA Reach Agreement On BNX Development Plan
NASDAQ.com
Tuesday, February 28, 2012 - 10:59am
tags:
FDA, BNX, BioDelivery Sciences, opiod addiction
Coronado Biosciences reports Phase 1 clinical trial results for TSO in Crohn's
Yahoo/Fly on the Wall
Tuesday, February 28, 2012 - 10:57am
tags:
Coronado Biosciences, TSO, Crohn's Disease
Tuesday's Bio Pharma Watch List
Seeking Alpha
Tuesday, February 28, 2012 - 10:50am
tags:
Jazz Pharmaceuticals, Questcor, Amarin, Elan
Amyris Misses on the Top and Bottom Lines
Yahoo/AP
Tuesday, February 28, 2012 - 10:48am
tags:
Amyris, earnings
Isis: If Trend Holds True, Watch For A Leap After Earnings
Seeking Alpha
Tuesday, February 28, 2012 - 10:45am
tags:
Isis, earnings
Bayer Could Finance ‘Significant’ Acquisition, CFO Says
Bloomberg
Tuesday, February 28, 2012 - 10:44am
tags:
M&A, Bayer
Impax Labs 4th-qtr profit rises
Reuters
Tuesday, February 28, 2012 - 10:43am
tags:
earnings, Impax Labs
3 Biotech Companies: 2 To Buy And 1 To Day Trade
Seeking Alpha
Tuesday, February 28, 2012 - 10:10am
tags:
Avanir, Spectrum Pharmaceuticals, Keryx, Aeterna Zentaris

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.